MedTrace Logo

eFast Diagnosis Performance in Guiding First Aid Resuscitation

NCT03699670 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 510

Last updated 2022-02-08

No results posted yet for this study

Summary

A lesion work-up associating clinical examination, extended focused ultrasound (eFAST including abdominal ultrasound \[right upper, left upper, and suprapubic quadrant\], bilateral anterior and lateral pleuropulmonary ultrasound, sub-xyphoid pericardial ultrasound, transcranial Doppler), and possibly chest and pelvis x-ray, can early diagnose the most severe traumatic lesions and guide first aid resuscitation and haemostasis. The protocol does not modify the diagnostic and therapeutic strategies applied in the participant centers.

The objective of the study is to evaluate the diagnosis performance of an initial lesion assessment by extended focused ultrasound (eFAST) (possibly associated with chest and pelvis x-ray) at the early phase of a severe trauma patient care in guiding first aid resuscitation and haemostasis.

The relevance will be judged on the therapeutic decisions taken (thoracic or pericardial drainage, thoracotomy or laparotomy, pelvic embolization, posture of a pelvic girdle, and early optimization of cerebral perfusion pressure) based on the initial ultrasound scan.

Conditions

  • eFast Diagnosis Performance in Guiding First Aid Resuscitation and Hemostasis

Sponsors & Collaborators

  • Société Française d'Anesthésie et de Réanimation

    collaborator OTHER

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Pierre BOUZAT · University Hospital of Grenoble Alpes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-03
Primary Completion
2019-12-13
Completion
2020-01-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03699670 on ClinicalTrials.gov